Stockreport

BRIEF-Retrophin Initiates Pivotal Phase 3 Clinical Trial Of Sparsentan For The Treatment Of Focal Segmental Glomerulosclerosis [Reuters]

RETROPHIN INC  (RTRX) 
Last retrophin inc earnings: 2/24 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.retrophin.com/investor-relations
PDF BRIEF-Retrophin Initiates Pivotal Phase 3 Clinical Trial Of Sparsentan For The Treatment Of Focal Segmental Glomerulosclerosis | Reuters Reuters Staff 1 Min Read April 3 [Read more]